Lee Ainslie Insulet Corp Transaction History

Maverick Capital LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$163.6 - $209.11 $414,071 - $529,257	2,531 New	2,531 $433,000
Q4 2021 Feb 14, 2022	SELL	$255.32 - $318.29 $767,747 - $957,098	-3,007 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$260.36 - $307.27 $782,902 - $923,960	3,007 New	3,007 $855,000
Q1 2021 May 17, 2021	SELL	$235.95 - $293.05 $702,423 - $872,409	-2,977 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$215.97 - $265.89 $642,942 - $791,554	2,977 New	2,977 $761,000

660

63.5M

385K

773K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $16B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.